STAT1h
Trump’s Justice Department defends Medicare drug price talks in case brought by Novartis
The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...
Trump’s DOJ Defends Drug Price Program in Third Circuit Brief
The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...
Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy Now
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds
We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
Ionis Continues to Expand Its Cardiology and Neurology Portfolio, Supporting Narrow Moat
Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...
FiercePharma9h
Genentech, Novartis join forces to raise awareness of food allergies’ impact on families
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
Novartis Invests $7.5M to Promote Early Prostate Cancer Testing in Vulnerable Communities
Novartis commits $7.5 million to the "Blitz the Barriers" campaign, aiming to raise awareness and encourage early testing for ...
Bernstein Reaffirms Their Buy Rating on Novartis AG (NOVN)
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price ...
BioSpace1d
5 Pharma Powerhouses Facing Massive Patent Cliffs—And What They’re Doing About It
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
FiercePharma1d
Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035
Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...
News Medical1d
Study shows rapid transformation in multiple sclerosis treatment in Finland
A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.